Medetomidine Hydrochloride, Vatinoxan Hydrochloride

489 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

489

Total Reports

Deaths Reported

670.0%

Death Rate

Active Ingredients

Medetomidine Hydrochloride, Vatinoxan Hydrochloride

Administration Routes

IntramuscularUnknownIntravenousSubcutaneous

Species Affected

Dog 480

Unknown 3

Cat 3

Human 2

Bobcat 1

Most Affected Breeds

Dog (unknown) 200

Retriever - Labrador 47

American Pit Bull Terrier 26

Shepherd Dog - German 18

Retriever - Golden 13

Dog (other) 11

Boxer (German Boxer) 10

Chihuahua 10

Shepherd Dog - Australian 10

Rottweiler 8

Most Reported Reactions

Lack of efficacy - NOS 251

Diarrhoea 45

Sedation prolonged 35

Bradycardia 25

Partial lack of efficacy 21

Tachycardia 19

Hypotension 16

Vomiting 16

Death 16

Involuntary defecation 15

Unrelated death 13

Immediate pain upon injection 12

Outcome Breakdown

Recovered/Normal

401 (81.8%)

Outcome Unknown

53 (10.8%)

Died

18 (3.7%)

Euthanized

15 (3.1%)

Ongoing

3 (0.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.